摘要
目的:测定急性冠状动脉综合征(ACS)患者血清中β2糖蛋白I(β2-GPI)抗体水平并探讨其临床意义。方法:采用ELISA法测定34例ACS患者和30例对照者血清中β2-GPI抗体水平,并进行相关统计学处理。结果:ACS患者血清中β2-GPI抗体水平明显高于对照组[(21.89±6.83)U/ml:(14.96±11.13)U/ml,P<0.01]。结论:在ACS血栓形成的过程中,免疫因素的介入,β2-GPI抗体可能为ACS患者冠状动脉血栓形成过程中一个不容忽视的环节。
Objective: To investigate level of anti-β2 glycoprotein I antibody (anti-|VGPI) and its clinical significance in patients with acute coronary syndrome (ACS). Methods:Sera from 34 patients with ACS and from 30 controls were tested for the level of anti-β2-GPI antibody using an ELISA technique. Results: Anti-β2-GPI antibody levels in patients with ACS were significantly than those in control group [ (21. 89±.6.83) U/ml: (14.96±11.13) U/ml, P< 0. 01]. Conclusion: Anti-bbbbbbbbb2-GPI glycoprotein I antibody may be a significant factor in formation of coronary thrombus.
出处
《心血管康复医学杂志》
CAS
2003年第1期24-25,共2页
Chinese Journal of Cardiovascular Rehabilitation Medicine
